Saturday, October 3, 2026
ExploreSearch
Via News
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Press releaseGlobeNewswire· April 9, 2026

TAP Real Estate Welcomes Jeff Jarrard as Chief Technology Officer

View original at globenewswire.com
TAP Real Estate Welcomes Jeff Jarrard as Chief Technology Officer Salt Lake City, UT, April 09, 2026 (GLOBE NEWSWIRE) -- TAP Real Estate (OTC: RWAX) is pleased to welcome Jeff Jarrard as Chief Technology Officer (CTO), where he will lead the buildout and development of TAPRealEstate.com, the company’s residential platf…
Opening lines of the source · GlobeNewswire · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • As payments, real estate assets, and registered ownership records increasingly move toward automated, programmable, and blockchain-based infrastructure, Jeff's leadership will help accelerate the implementation of these systems at TAP Real Estate

    60% confidence

  • Jeff Jarrard brings a rare combination of applied artificial intelligence, large-scale data infrastructure, and financial systems expertise within Fortune 100 environments which is critical for where real estate and global financial systems are heading

    60% confidence

  • The real estate category needs to be rethought from the ground up across transaction workflows, programmability, and liquidity for buyers, sellers, owners, and operators

    60% confidence

  • TAP is already running far ahead of where the market is in the real estate industry with their advancements in digital wallets, tokenized assets, blockchain registries and more

    60% confidence

  • Real estate is in the middle of an existential change where age of U.S. homebuyers, pricing, time on market, middlemen, and legacy technologies are contributing to friction across residential and commercial sectors

    60% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com